27
Participants
Start Date
February 28, 2007
Primary Completion Date
February 28, 2014
Study Completion Date
April 30, 2020
GM-K562 vaccine
The vaccine will be administered over 1 cycle of 7 weeks, that begins 1 month after stem cell transplant. The vaccine will be given 6 times over 2 months -- once a week for three weeks then every other week for 3 vaccines.
stem cell transplantation
Participants will be admitted to the hospital for approximately 8 days to receive chemotherapy and stem cell transplantation
Dana-Farber Cancer Institute, Boston
Brigham and Women's Hospital
OTHER
Dana-Farber Cancer Institute
OTHER